BLRX
BioLineRx Ltd. - American Depositary Shares (BLRX)
$77
About BioLineRx Ltd. - American Depositary Shares (BLRX)
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Details
Daily high
$1.92
Daily low
$1.70
Price at open
$1.92
52 Week High
$3.95
52 Week Low
$1.70
Market cap
9.3M
Dividend yield
-
Volume
15,158
Avg. volume
11,814
P/E ratio
-1.02
BioLineRx Ltd. - American Depositary Shares News
Details
Daily high
$1.92
Daily low
$1.70
Price at open
$1.92
52 Week High
$3.95
52 Week Low
$1.70
Market cap
9.3M
Dividend yield
-
Volume
15,158
Avg. volume
11,814
P/E ratio
-1.02